Prostate Cancer Roundtable

Join Drs. Richard Stock, Bobby Liaw, and John Sfakianos as they discuss the current landscape of prostate cancer management. The faculty break down the discussion into four parts: the treatment of localized high-risk prostate cancer, new developments in radiotherapeutic treatment, managing hormone refractory disease, and new imaging and treatment approaches in recurrent prostate cancer.

Video 1: Treatment of localized high-risk prostate cancer

Topics include the multi-modal approach to treatment, surgery in advanced disease, hormone therapy, and radiation following prostatectomy.

Up Next

Video 1: Treatment of localized high-risk prostate cancer
Video 2: New developments in radiotherapeutics management of prostate cancer
Video 3: Managing hormone refractory prostate cancer
Video 4: New imaging and treatment approaches in recurrent prostate cancer

About the Panel

Richard Stock, MD

  • Professor and Director of Genitourinary Radiation Oncology
  • Icahn School of Medicine at Mount Sinai

Bobby Liaw, MD

  • Clinical Director of Genitourinary Oncology
  • Mount Sinai Health System

John Sfakianos, MD

  • Assistant Professor of Urology and Urologic Oncology
  • Icahn School of Medicine at Mount Sinai

This video roundtable was produced by the specialized content division of Frontline Medical Communications. The faculty received a modest honorarium from Frontline Medical Communications for their participation in this roundtable.

The faculty was solely responsible for the content presented in the videos.

Disclosures

Dr. Stock has no potential conflicts of interest to disclose.

Dr. Liaw discloses that he has is on the advisory board for Amgen and Baxter, and he has received research grants from Bayer, Janssen, and Sanofi.

Dr. Sfakianos has no potential conflicts of interest to disclose.